Human CD257 (BAFF, BLYS) Antibody from BIOLEGEND
Search, find, compare suppliers for anti-Human CD257 (BAFF, BLYS) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD257 (BAFF, BLYS) |
| Clone | 1D6 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1, kappa |
| Format | TotalSeq™-B oligomer conjugate |
| Size | 10 µg |
| Concentration | n/a |
| Applications | PG - Quality tested |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | TotalSeq™-B0863 anti-human CD257 (BAFF, BLYS). BAFF, also known as B cell activating factor, tumor necrosis factor ligand superfamily 13B, B lymphocyte stimulator (BLYS), TNF and APOL-related leukocyte expressed ligand 1 (TALL1), and TNF homolog, activates apoptosis, NF-κB, and JNK (THANK). BAFF is a type II transmembrane protein and is a member of the tumor necrosis factor ligand superfamily. BAFF can be proteolytically cleaved to form a soluble protein. BAFF, like other TNF ligand family members, forms homotrimers. The predicted molecular weight of a BAFF monomer is approximately 31 kD. BAFF is expressed on peripheral blood B and T lymphocytes, monocytes, macrophages, and dendritic cells. It is upregulated by IFN-γ and downregulated by PMA/ionomycin treatment. |
| Immunogen | Human CD257 transfected murine cell line. |
| Other Names | BAFF, BLYS, TNFSF13b, B cell activating factor, tumor necrosis factor ligand superfamily 13B, B lymphocyte stimulator (BLYS), TNF and APOL-related leukocyte expressed ligand 1 (TALL1), TNF homolog that activates apoptosis, NF-??B and JNK (THANK) |
| Gene, Accession # | Gene ID: 10673 |
| Catalog # | 366515 |
| Price | $369 |
| Order / More Info | Human CD257 (BAFF, BLYS) Antibody from BIOLEGEND |
| Product Specific References | n/a |
BIOLEGEND
BIOLEGEND
8999 BioLegend Way
San Diego CA 92121
P: (858) 455-9588
P: 1-877-Bio-Legend (246-5343)
F: (858) 455-9587
customerserv@biolegend.com
http://www.biolegend.com
Profile of BIOLEGEND
Return to Antibodies